ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978

Centers Can Collaborate Well with Industry, Albert LoBuglio Says

May 7, 1999

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006